Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
The American Surgeon|January 16, 2013
Novel prognostic scoring system after surgery for Klatskin tumorGernot M Kaiser, Andreas Paul, George Sgourakis, et al.Journal of Surgical Oncology|September 29, 2011
Ten-year survival of esophageal cancer after an en-bloc esophagectomyArzu Oezcelik, Gernot M Kaiser, Wolfgang Niebel, et al.Investigational New Drugs|October 13, 2011
Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumoursTanja Trarbach, Beate Schultheis, Thomas C Gauler, et al.Journal of the American College of Surgeons|February 21, 2009
Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patientsHauke Lang, Georgios C Sotiropoulos, George Sgourakis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptorUdo Vanhoefer, Mitra Tewes, Federico Rojo, et al.Journal of Cancer Research and Clinical Oncology|November 30, 2016
A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO)Jalid Sehouli, Oliver Tomè, Desislava Dimitrova, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapyMichael I Koukourakis, Alexandra Giatromanolaki, Efthimios Sivridis, et al.BMC Cancer|February 12, 2013
Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junctionMarkus Moehler, Ines Gockel, Hans-Peter Roessler, et al.Oncotarget|December 30, 2017
AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancerMelanie Kripp, Nicole Prasnikar, Ursula Vehling-Kaiser, et al.Onkologie|May 1, 2010
[Specific treatment situations in metastatic colorectal cancer]Dirk Arnold, Hans-Joachim Schmoll, Hauke Lang, et al.Pageof 5